Medtronic's implantable OCD treatment okayed by FDA

Darren Murph
D. Murph|02.24.09

Sponsored Links

Medtronic's implantable OCD treatment okayed by FDA
Looks like those brain pacemaker researchers are a bit late on this one, as folks at Medtronic are apt to get the jump on advanced OCD treatment given a recent FDA approval of their device. Hailed as the first implantable device "designed to deliver electrical therapy to the brain to suppress symptoms associated with severe obsessive-compulsive disorder," the Reclaim DBS (deep brain stimulation) Therapy was said to be able to treat OCD patients in cases where drugs and psychotherapy failed. Understandably, Medtronic is doing everything it can to get the product out by the middle of this year, and following up on its good fortune, it also proclaimed that it had started up a randomized clinical trial of DBS for treatment-resistant depression. There's no mention of an expected price, but apparently only 4,000 or so will be needed each year.

[Via Vos Iz Neias, thanks yossi]
All products recommended by Engadget are selected by our editorial team, independent of our parent company. Some of our stories include affiliate links. If you buy something through one of these links, we may earn an affiliate commission.
Popular on Engadget